Commentary: Periodontal Treatment and Inflammation in Diabetes: Association or Causation?

scientific article published on October 2016

Commentary: Periodontal Treatment and Inflammation in Diabetes: Association or Causation? is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1902/JOP.2016.160433
P932PMC publication ID5842079
P698PubMed publication ID27677805

P2093author name stringAnwar T Merchant
Michele J Josey
P2860cites workMarkers of systemic bacterial exposure in periodontal disease and cardiovascular disease risk: a systematic review and meta-analysisQ37021287
Double-Blind, Randomized Study Evaluating the Glycemic and Anti-inflammatory Effects of Subcutaneous LY2189102, a Neutralizing IL-1β Antibody, in Patients With Type 2 DiabetesQ37022686
Body mass index as a predictive factor of periodontal therapy outcomes.Q37414227
Periodontal disease and stroke: a meta-analysis of cohort studiesQ38203003
Association between periodontal disease and its treatment, flow-mediated dilatation and carotid intima-media thickness: a systematic review and meta-analysisQ38228368
Effect of overweight/obesity on response to periodontal treatment: systematic review and a meta-analysisQ38315025
The IL-1 Pathway in Type 2 Diabetes and Cardiovascular Complications.Q38594140
Efficacy of non-surgical periodontal therapy in the management of chronic periodontitis among obese and non-obese patients: a systematic review and meta-analysis.Q38785655
Systemic Inflammatory Biomarkers and Their Association With Periodontal and Diabetes-Related Factors in the Diabetes and Periodontal Therapy Trial, A Randomized Controlled TrialQ39827155
Is obesity associated with healing after non-surgical periodontal therapy? A local vs. systemic evaluationQ41050921
Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjectsQ42797512
Short-term effects of intensive periodontal therapy on serum inflammatory markers and cholesterolQ45277110
Effects of periodontal treatment on glycemic control in type 2 diabetic patients: a meta-analysis of randomized controlled trialsQ51309678
Abdominal Obesity and the Risk of All-Cause, Cardiovascular, and Cancer MortalityQ57321497
Chronic Inflammatory Disorders and Risk of Type 2 Diabetes Mellitus, Coronary Heart Disease, and StrokeQ57388112
Treatment of periodontitis and endothelial functionQ79848712
A proposed model linking inflammation to obesity, diabetes, and periodontal infectionsQ81458916
Obesity, Inflammation, and Insulin ResistanceQ22250939
Influence of periodontal therapy on C-reactive protein level: a systematic review and meta-analysisQ26853400
Inflammatory Mechanisms in ObesityQ29617932
Interleukin-1-receptor antagonist in type 2 diabetes mellitusQ29619001
Association between chronic periodontal disease and obesity: a systematic review and meta-analysisQ33665153
The effect of nonsurgical periodontal therapy on hemoglobin A1c levels in persons with type 2 diabetes and chronic periodontitis: a randomized clinical trialQ33874448
Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alphaQ34190131
Periodontal diseases and the risk of coronary heart and cerebrovascular diseases: a meta-analysisQ34354157
Tumor necrosis factor alpha inhibits signaling from the insulin receptorQ35304189
Effects of gevokizumab on glycemia and inflammatory markers in type 2 diabetesQ36109128
Periodontal associations in cardiovascular diseases: The latest evidence and understandingQ36217688
Obesity, inflammation, and periodontal diseaseQ36798998
P433issue10
P407language of work or nameEnglishQ1860
P304page(s)1113-1116
P577publication date2016-10-01
P1433published inJournal of PeriodontologyQ6295732
P1476titleCommentary: Periodontal Treatment and Inflammation in Diabetes: Association or Causation?
P478volume87

Search more.